Overview of Avian Influenza Market Report Helps In Providing Scope and Definitions, Key Findings, Growth Drivers, and Various Dynamics.
Highly pathogenic avian influenza virus (HPAI) H5N1 infected nearly 202 persons globally and killed 113 as of April 30, 2006. Most of the patients who were infected were mainly exposed to dead or ill birds or were involved in the slaughtering or preparation of birds as human food. Various epidemiologic studies also revealed that the patient even not slaughtered, processed or cooked birds. While looking for work before his illness, the patient merely visited 9 food markets which sold live birds. The food markets were big, clean, and mostly well managed and also had vegetables, raw and cooked meats, fruits, food flavors, beverages, and other good vendors. Avian flu can be for the most part named as Avian Flu or winged animal influenza. Avian Flu is an irresistible viral illness that is brought about by contaminated birds. Avian flu immunization may incorporate distinctive antiviral medicines and requires continuous monitoring in case of human infection. Avian Influenza treatment and analysis methodology require the early detection of the viral strains by various immunological tests.
Gets Sample of Global Avian Influenza Market Report @ https://www.arcognizance.com/enquiry-sample/1220660
Widespread growth of bird population, increasing individuals with low immunity are easily susceptible to avian influenza virus. The demand for avian influenza vaccine is rising among the hospitals and ICUs, owing to surge in these cases. Avian flu influenzas are categorized clinically on the basis of its pathogenicity such as high pathogenicity or low pathogenicity. People who work in poultry, move to and fro from virus infected countries come in contact with infected birds by cooking or raw eating are highly involved in the risk of transmission of avian flu. This type of A(H5N1) virus subtype, is pathogenic, and its first case was reported in Hong Kong in 1997. Repeated outbreaks of avian flu in poultry farms have heavily impacted livelihoods as well as the economy and international trade in neighboring countries.
The global Avian Influenza Market is segmented on the basis of drug type, application and geography. Based on the drug type, the global market is bifurcated into Antivirals, Combination treatment, Prophylactic antibiotics, Steroids and other immunosuppressants and others. On the basis of application, the global Avian Influenza Market is segmented into Hospitals and Clinics, Home Care, Ambulatory Care Centers and Emergency Medical Services (EMS). Geographically, the market is divided into North America, Europe, Asia-Pacific (APAC), Latin America and Middle East & Africa (MEA).
Since the CoVID-19 outbreak in December 2019, the virus has spread worldwide. CoVID-19 is impacting business globally and is further expected to influence this market as well. CoVID-19 has been affecting global supply chains and thereby throwing the demand and supply gap haywire, leaving significant financial impact. This report analyzes the impact of CoVID-19 on this industry and provides apt conclusions for key business stakeholders. The key players operating within the global Avian Influenza Market include Hoffmann-La Roche Inc., GlaxoSmithKline plc, Forest Pharmaceuticals Inc., and BioCryst Pharmaceuticals, CAVAC, Hoffmann-La Roche Inc., GlaxoSmithKline plc, Forest Pharmaceuticals Inc., and BioCryst Pharmaceuticals.
Browse Global Avian Influenza Industry Report @ https://www.arcognizance.com/report/avian-influenza-market-global-industry-analysis-size-share-trends-and-forecast-2015-2025
Table of Content:
Chapter One: Market Introduction
Chapter Two: Executive Summary
Chapter Three: Global Avian Influenza Market – Key Industry Dynamics
Chapter Four: Global Avian Influenza Market – Analysis and Revenue Forecast, 2015-2025 – By Drug Type
- 1. Antivirals
- 2. Combination treatment
- 3. Prophylactic antibiotics
- 4. Steroids
- 5. Immunosuppressants
- 6. Others
Chapter Five: Global Avian Influenza Market – Analysis and Revenue Forecast, 2015-2025 – By Application
- 1. Hospitals and Clinics
- 2. Home Care
- 3. Ambulatory Care Centers
- 4. Emergency Medical Services (EMS)
Chapter Six: Global Avian Influenza Market – Analysis and Revenue Forecast, 2015-2025 – By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
Chapter Seven: North America Avian Influenza Market – Analysis and Revenue Forecast, 2015-2025
Chapter Eight: Europe Avian Influenza Market – Analysis and Revenue Forecast, 2015-2025
Chapter Nine: Asia-Pacific Avian Influenza Market – Analysis and Revenue Forecast, 2015-2025
Chapter Ten: Latin America Avian Influenza Market – Analysis and Revenue Forecast, 2015-2025
Chapter Eleven: Middle East & Africa Avian Influenza Market – Analysis and Revenue Forecast, 2015-2025
Chapter Twelve: Competitive Analysis
Competition Dashboard
Company Profiles
- 1.2.1. Hoffmann-La Roche Inc.
- 1.2.1.1. Company Details
- 1.2.1.2. Product Portfolio
- 1.2.1.3. Financial Overview
- 1.2.1.4. Main Business Overview
- 1.2.1.5. News
- 1.2.2. GlaxoSmithKline plc.
- 1.2.3. Forest Pharmaceuticals Inc
- 1.2.4. BioCryst Pharmaceuticals
- 1.2.5. CAVAC
- 1.2.6. Hoffmann-La Roche Inc
- 1.2.7. GlaxoSmithKline plc
- 1.2.8. Forest Pharmaceuticals Inc
- 1.2.9. BioCryst Pharmaceuticals
Chapter Thirteen: Appendix
Chapter Fourteen: Research Conclusions
Make Enquiry of Avian Influenza Market Report @ https://www.arcognizance.com/enquiry-before-buying/1220660
Buy Avian Influenza Market Report @ https://www.arcognizance.com/purchase/1220660?license=single
About us: Analytical Research Cognizance (ARC) is a trusted hub for research reports that critically renders accurate and statistical data for your business growth. Our extensive database of examined market reports places us amongst the best industry report firms. Our professionally equipped team further strengthens ARC’s potential. ARC works with the mission of creating a platform where marketers can have access to informative, latest and well researched reports. To achieve this aim our experts tactically scrutinize every report that comes under their eye.
Contact Us:
Ranjeet Dengale
Director Sales
Analytical Research Cognizance
+1 (646) 403-4695, +91 90967 44448
sales@arcognizance.com
